FI71321C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,,3,3a,4,5,6,7-oktahydro-3,7a-diazacyklohepta/j,k/fluorene r - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,,3,3a,4,5,6,7-oktahydro-3,7a-diazacyklohepta/j,k/fluorene r Download PDF

Info

Publication number
FI71321C
FI71321C FI824155A FI824155A FI71321C FI 71321 C FI71321 C FI 71321C FI 824155 A FI824155 A FI 824155A FI 824155 A FI824155 A FI 824155A FI 71321 C FI71321 C FI 71321C
Authority
FI
Finland
Prior art keywords
octahydro
benzyl group
compounds
diazacyclohepta
therapeutic
Prior art date
Application number
FI824155A
Other languages
English (en)
Finnish (fi)
Other versions
FI71321B (fi
FI824155A0 (fi
FI824155L (fi
Inventor
Jean Bertin
Jonathan Frost
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI824155A0 publication Critical patent/FI824155A0/fi
Publication of FI824155L publication Critical patent/FI824155L/fi
Application granted granted Critical
Publication of FI71321B publication Critical patent/FI71321B/fi
Publication of FI71321C publication Critical patent/FI71321C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Revetment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Reversible Transmitting Devices (AREA)
  • Glass Compositions (AREA)
FI824155A 1981-12-03 1982-12-02 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,,3,3a,4,5,6,7-oktahydro-3,7a-diazacyklohepta/j,k/fluorene r FI71321C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8122643 1981-12-03
FR8122643A FR2517679A1 (fr) 1981-12-03 1981-12-03 Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
FI824155A0 FI824155A0 (fi) 1982-12-02
FI824155L FI824155L (fi) 1983-06-04
FI71321B FI71321B (fi) 1986-09-09
FI71321C true FI71321C (fi) 1986-12-19

Family

ID=9264634

Family Applications (1)

Application Number Title Priority Date Filing Date
FI824155A FI71321C (fi) 1981-12-03 1982-12-02 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,,3,3a,4,5,6,7-oktahydro-3,7a-diazacyklohepta/j,k/fluorene r

Country Status (18)

Country Link
US (1) US4503058A (ja)
EP (1) EP0082040B1 (ja)
JP (1) JPS58109487A (ja)
AT (1) ATE17485T1 (ja)
AU (1) AU553493B2 (ja)
CA (1) CA1196329A (ja)
DE (1) DE3268605D1 (ja)
DK (1) DK535082A (ja)
ES (1) ES8401488A1 (ja)
FI (1) FI71321C (ja)
FR (1) FR2517679A1 (ja)
GR (1) GR77848B (ja)
HU (1) HU186180B (ja)
IL (1) IL67400A (ja)
NO (1) NO824040L (ja)
NZ (1) NZ202688A (ja)
PT (1) PT75925B (ja)
ZA (1) ZA828877B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665183A (en) * 1985-12-20 1987-05-12 American Home Products Corp. Process for preparing 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof useful for the treatment of cognitive impairments
US4624954A (en) * 1985-12-20 1986-11-25 American Home Products Corporation 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD129791A5 (de) * 1976-04-13 1978-02-08 Synthelabo Verfahren zur herstellung von naphtyridinderivaten
US4228168A (en) * 1978-11-22 1980-10-14 Tanabe Seiyaku Co., Ltd. Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof
JPS55161389A (en) * 1979-06-01 1980-12-15 Ngk Spark Plug Co Method of connecting porcelain insulator to fitting

Also Published As

Publication number Publication date
FR2517679A1 (fr) 1983-06-10
NZ202688A (en) 1985-01-31
FI71321B (fi) 1986-09-09
EP0082040B1 (fr) 1986-01-15
DK535082A (da) 1983-06-04
FR2517679B1 (ja) 1984-01-27
HU186180B (en) 1985-06-28
NO824040L (no) 1983-06-06
DE3268605D1 (en) 1986-02-27
PT75925B (fr) 1985-12-20
ES517874A0 (es) 1983-12-01
AU553493B2 (en) 1986-07-17
ATE17485T1 (de) 1986-02-15
FI824155A0 (fi) 1982-12-02
JPS58109487A (ja) 1983-06-29
IL67400A (en) 1985-07-31
AU9107682A (en) 1983-06-09
CA1196329A (en) 1985-11-05
ZA828877B (en) 1983-09-28
GR77848B (ja) 1984-09-25
FI824155L (fi) 1983-06-04
PT75925A (fr) 1983-01-01
ES8401488A1 (es) 1983-12-01
EP0082040A1 (fr) 1983-06-22
IL67400A0 (en) 1983-05-15
US4503058A (en) 1985-03-05

Similar Documents

Publication Publication Date Title
FI91401C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
DE3783988T2 (de) Zyklische enolderivate, herstellung und anwendung.
JP3499905B2 (ja) グアニジンアルキル−1,1−ビスホスホン酸誘導体、その製法およびその使用
CN115190815A (zh) 芳基环己基胺衍生物及其在精神障碍的治疗中的用途
HUT75307A (en) 5h-indeno[1,2-b]pyrazine-2,3-dione derivaties, preparation thereof and drugs containing same
KR20160089516A (ko) 에테르 측쇄를 함유한 n-치환 이미다졸 카르복실산 에스테르 키랄 화합물, 제조 방법 및 용도
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
EP2896626A1 (en) Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
SU891674A1 (ru) 2-Бромэргозин или его аддитивно-кислые соли,про вл ющие гипотензивную активность
JPS62212322A (ja) 医薬組成物および処置法
FR2776660A1 (fr) Diazepino-indoles de phosphodiesterases iv
FI71321C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,,3,3a,4,5,6,7-oktahydro-3,7a-diazacyklohepta/j,k/fluorene r
FI65250C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-cetyl-1,2,3,3a,4,5,6,7-oktahydro-3,6,7a-triaza-syklohepta (j)fluorenderivat
US3843796A (en) Antihypertensive agents
BRPI0812919B1 (pt) composição farmacêutica que compreende um composto e kit
BG60317B2 (bg) Инденоиндолови съединения
FI86733B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbar piperazinkarboxylsyra.
SU1468424A3 (ru) Способ получени производных гидантоина
KR910006128B1 (ko) N-치환 이미다졸 유도체
JPS61500437A (ja) n−プロパノ−ルアミン誘導体のエ−テル
IE62011B1 (en) Piperazine derivatives
US5216017A (en) Pyrrolo[2,3-b]indole-ketones and analogs
JPH0154326B2 (ja)
WO1994029315A1 (en) 1,2,3,4-TETRAHYDROPYRROLO[1,2-a]PYRAZINES
WO2004087172A1 (ja) T型カルシウムチャネル阻害剤

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SYNTHELABO